Mylan (Nasdaq: MYL) reported earnings on May 2. Here are the numbers you need to know.

The 10-second takeaway
 For the quarter ended March 31 (Q1), Mylan missed estimates on revenues and met expectations on earnings per share.

Compared to the prior-year quarter, revenue expanded slightly. Non-GAAP earnings per share increased significantly. GAAP earnings per share dropped.

Gross margins expanded, operating margins shrank, net margins contracted.

Revenue details
 Mylan reported revenue of $1.63 billion. The 16 analysts polled by S&P Capital IQ foresaw sales of $1.69 billion on the same basis. GAAP reported sales were the same as the prior-year quarter's.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
 EPS came in at $0.62. The 20 earnings estimates compiled by S&P Capital IQ anticipated $0.62 per share. Non-GAAP EPS of $0.62 for Q1 were 19% higher than the prior-year quarter's $0.52 per share. GAAP EPS of $0.27 for Q1 were 10.0% lower than the prior-year quarter's $0.30 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
 For the quarter, gross margin was 42.5%, 50 basis points better than the prior-year quarter. Operating margin was 13.2%, 420 basis points worse than the prior-year quarter. Net margin was 6.6%, 150 basis points worse than the prior-year quarter. (Margins calculated in GAAP terms.)

Looking ahead
 Next quarter's average estimate for revenue is $1.76 billion. On the bottom line, the average EPS estimate is $0.69.

Next year's average estimate for revenue is $7.14 billion. The average EPS estimate is $2.87.

Investor sentiment
 The stock has a four-star rating (out of five) at Motley Fool CAPS, with 536 members out of 571 rating the stock outperform, and 35 members rating it underperform. Among 171 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 163 give Mylan a green thumbs-up, and eight give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Mylan is outperform, with an average price target of $31.92.